A Multi-Omics Platform for Comprehensive pHLA Target Discovery & Validation
- Leveraging immunopeptidomics to profile and measure cell surface proteins that guide therapeutic decision-making
- Harnessing immunopeptidomics insights to discover and confirm new peptide targets for antibody therapies
- Tackling issues of low-abundance targets and assay sensitivity through cutting-edge technologies and instruments